1.0I2Uhttps://i2u.ca/fradminhttps://i2u.ca/fr/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="iI9Tbl0KGH"><a href="https://i2u.ca/fr/our-insights/">Nos idées</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://i2u.ca/fr/our-insights/embed/#?secret=iI9Tbl0KGH" width="600" height="338" title="« Our Insights » — I2U" data-secret="iI9Tbl0KGH" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://i2u.ca/wp-includes/js/wp-embed.min.js </script>Our Insights I2U has created several case studies to identity and illuminate the discrete challenges preventing the value maximization of breakthrough medicines, and lessons learned for future innovations. To uncover these challenges, I2U conducted interviews with a wide range of system leaders and stakeholders, supported by extensive background research on implementation challenges and approaches across […]https://i2u.ca/wp-content/uploads/2023/05/virus.png6464